|
VENICE, Fla., Aug. 19 /PRNewswire-FirstCall/ -- SinoFresh HealthCare, Inc., (OTC
Bulletin Board: SFSH - News) announced preliminary results today from a successful
in vivo pilot study indicating that its patented SinoFresh® nasal spray was shown
to be useful in controlling the MRSA "super-bug" in the nasal passages. This study
utilized a recognized scientific model intended to demonstrate SinoFresh® nasal
spray's ability to kill MRSA hiding in the nasal passages. These favorable efficacy
results follow an earlier, successful in vitro study that was conducted at the Public
Health Research Institute under the direction of Dr. Barry Kreiswirth, director
of the Tuberculosis Center and Hospital Infections Program.
|
|
The study showed that SinoFresh® nasal spray used three times daily appeared to
effectively eliminate MRSA in the noses of the test animals while leaving enough
normal microbes to keep a normal population in the nasal passages," according to
Dr. John Todhunter, consultant to SinoFresh, who oversaw the study conducted at
Virion Systems in Rockville, MD.
|
|
MRSA (which stands for Methicillin Resistant Staphylococcus aureus) is a growing
concern in the health care community. It incubates in the nasal passages and then
gets on the skin where it can cause severe, virulent infections. The effect of MRSA
can lead to disfigurement and sometimes death. MRSA is also highly antibiotic resistant,
making MRSA infections difficult to treat. It is believed that approximately 2 -
3 million persons in the U.S. walk around carrying MRSA in their nasal passages
at any time and elimination or severe reduction of nasal MRSA colonies is seen as
a potentially important weapon in fighting the spread of MSRA. The antibiotic Mupirocin
is currently used to reduce nasal MRSA loads.
|
|
SinoFresh® nasal spray attacks MRSA in the nasal passages by destroying the "super-bug's"
cell walls and membranes by physical means rather than by an antibiotic mechanism
involving attack on the metabolism of the microbes as occurs with the use of antibiotics.
"Since bacteria can in effect change their metabolism to be resistant to antibiotics,
but can't very well change the laws of physics the chances for development of resistance
to SinoFresh® Nasal Spray's mode of killing them is much lower said Dr. Todhunter."
|
|
According to William Wilferth, VP for Research and Development at SinoFresh, "These
results have exceeded our expectations. The positive results of this in vivo study
gives us the solid scientific platform we have needed in order to advance our efforts
to fight MRSA to the next level."
|
|
Charles Fust, CEO of SinoFresh, noted that the data reported is extremely encouraging
and that there is a significant market need for new methods to address MRSA control
which is believed to be as many as 80 to 100 million treatments annually in the
United States alone
|
This product, SinoFresh®, has shown to kill these organisms in vitro:
1. Haemophilus Influenzae (H1)
2. Moraxella (Branhamella) Cattarrhalis
3. Streptococcus Pyogenes
4. Staphylococcus Aureaus (MRSA)
5. Staphylococcus Aureaus
6. Pseudomonas
7. Escherichia Coli
|